Pituitary-adrenal responses to oxotremorine and acute stress in male and female M1 muscarinic receptor knockout mice: Comparisons to M2 muscarinic receptor knockout mice

Journal of Neuroendocrinology

Volumn 20, Issue 5, 2008, Pages 617-625

  Rhodes, Michael E ^a   Rubin, R T ^b   Mcklveen, J M ^a   Karwoski, T E ^c   Fulton, B A ^c   Czambel, R K ^c  

^a SAINT VINCENT COLLEGE   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cholinergic; Diergism; Knockout; Muscarinic; Sex differences

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; OXOTREMORINE; SODIUM CHLORIDE;

ACUTE STRESS; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEMALE; HORMONE RESPONSE; HORMONE SENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE; STRAIN DIFFERENCE; WILD TYPE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; FEMALE; MALE; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; OXOTREMORINE; PITUITARY-ADRENAL SYSTEM; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; SODIUM CHLORIDE; STRESS, PSYCHOLOGICAL; SYNAPSES;

EID: 42149087673     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01700.x     Document Type: Article

References (48)

1. Brann MR, Ellis J, Jorgensen H, Hill-Eubanks D, Jones SV. Muscarinic acetylcholine receptor subtypes: Localization and structure/function. Prog Brain Res 1993; 98: 121-127.
2. Levey AI. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 1993; 52: 441-448.
3. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV, Wolfe BB. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: Distribution of m4 and m5 receptors in rat brain. Mol Pharmacol 1993; 43: 149-157.
4. Matsui M, Yamada S, Oki T, Manabe T, Taketo MM, Ehlert FJ. Functional analysis of muscarinic acetylcholine receptors using knockout mice. Life Sci 2004; 75: 2971-2981.
5. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996; 10: 69-99.
6. Tzavara ET, Bymaster FP, Felder CC, Wade M, Gomeza J, Wess J, McKinzie DL, Nomikos GG. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 2003; 8: 673-679.
7. Baghdoyan HA, Lydic R, Fleegal MA. M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation. J Pharmacol Exp Ther 1998; 286: 1446-1452.
8. Kremin T, Gerber D, Giocomo LM, Huang SY, Tonegawa S, Hasselmo ME. Muscarinic suppression in stratum radiatum of CA1 shows dependence on presynaptic M1 receptors and is not dependent on effects at GABA(B) receptors. Neurobiol Learn Mem 2006; 85: 153-163.
9. Gautam D, Duttaroy A, Cui Y, Han SJ, Deng C, Seeger T, Alzheimer C, Wess J. M1-M3 muscarinic acetylcholine receptor-deficient mice: Novel phenotypes. J Mol Neurosci 2006; 30: 157-160.
10. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 1997; 94: 13311-13316.
11. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96: 1692-1697.
12. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 2001; 98: 14096-14101.
13. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001; 410: 207-212.
14. Wess J. Muscarinic acetylcholine receptor knockout mice: Novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004; 44: 423-450.
15. Miyakawa T, Yamada M, Duttaroy A, Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 2001; 21: 5239-5250.
16. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Silva AJ. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003; 6: 51-58.
17. Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, Brodkin J, Shannon H, Xia B, Duttaroy A, Deng CX, Wess J. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 2001; 68: 2457-2466.
18. Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 2002; 22: 1709-1717.
19. Rubin RT, Sekula LK, O'Toole S, Rhodes ME, Czambel RK. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men. Neuropsychopharmacology 1999; 20: 434-446.
20. Rubin RT, Rhodes ME, O'Toole S, Czambel RK. Sexual diergism of hypothalamo-pituitary-adrenal cortical responses to low-dose physotigmine in elderly vs. young women and men. Neuropsychopharmacology 2002; 26: 672-681.
21. Rhodes ME, O'Toole SM, Wright SL, Czambel RK, Rubin RT. Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Res Bull 2001; 54: 101-113.
22. Rhodes ME, Billings TE, Czambel RK, Rubin RT. Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M(2) muscarinic receptor knockout mice. J Neuroendocrinol 2005; 17: 817-826.
23. Fisahn A, Yamada M, Duttaroy A, Gan JW, Deng CX, McBain CJ, Wess J. Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron 2002; 33: 615-624.
24. Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, Wess J. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96: 10483-10488.
25. Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 2003; 17: 1403-1410.
26. Sanchez C, Lembol HL. The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice. Pharmacol Toxicol 1994; 74: 35-39.
27. Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P. M1 receptor agonist activity is not a requirement for muscarinic antinociception. J Pharmacol Exp Ther 1997; 281: 868-875.
28. Espinola EB, Oliveira MG, Carlini EA. Differences in central and peripheral responses to oxotremorine in young and aged rats. Pharmacol Biochem Behav 1999; 62: 419-423.
29. Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 2002; 62: 1084-1093.
30. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 1989; 35: 596-600.
31. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 403-409.
32. Laurent V, Kimble A, Peng B, Zhu P, Pintar JE, Steiner DF, Lindberg I. Mortality in 7B2 null mice can be rescued by adrenalectomy: Involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci USA 2002; 99: 3087-3092.
33. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993; 58: 319-379.
34. Le Mevel JC, Abitbol S, Beraud G, Maniey J. Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats. Endocrinology 1979; 105: 812-817.
35. Rimanoczy A, Slamberova R, Riley MA, Vathy I. Adrenocorticotropin stress response but not glucocorticoid-negative feedback is altered by prenatal morphine exposure in adult male rats. Neuroendocrinology 2003; 78: 312-320.
36. Janossy A, Li JY, Saez JM. Characterisation of the muscarinic receptor subtype M3 in the bovine zona fasciculata-reticularis cells by receptor binding, mRNA and functional studies. J Endocrinol 1999; 163: 329-336.
37. Clyne CD, Walker SW, Nicol MR, Williams BC. The M3 muscarinic receptor mediates acetylcholine-induced cortisol secretion from bovine adrenocortical zona fasciculata/reticularis cells. Biochem Pharmacol 1994; 47: 1145-1150.
38. Young EA. Sex differences in response to exogenous corticosterone: A rat model of hypercortisolemia. Mol Psychiatry 1996; 1: 313-319.
39. Moidel MA, Belz EE, Czambel RK, Rubin RT, Rhodes ME. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses. J Pharmacol Toxicol Methods 2006; 53: 264-271.
40. Avissar S, Egozi Y, Sokolovsky M. Biochemical characterization and sex dimorphism of muscarinic receptors in rat adenohypophysis. Neuroendocrinology 1981; 32: 303-309.
41. Narang N. In situ determination of M1 and M2 muscarinic receptor binding sites and mRNAs in young and old rat brains. Mech Ageing Dev 1995; 78: 221-239.
42. Aubert I, Cecyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. Eur J Pharmacol 1992; 217: 173-184.
43. Vaucher E, Reymond I, Najaffe R, Kar S, Quirion R, Miller MM, Franklin KB. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol Aging 2002; 23: 87-95.
44. Rhodes ME, Rubin RT. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: A selective review. Brain Res Brain Res Rev 1999; 30: 135-152.
45. Pinter I, Moszkovszkin G, Nemethy Z, Makara GB. Muscarinic M1 and M3 receptors are present and increase intracellular calcium in adult rat anterior pituitary gland. Brain Res Bull 1999; 48: 449-456.
46. Mukherjee A, Snyder G, McCann SM. Characterization of muscarinic cholinergic receptors on intact rat anterior pituitary cells. Life Sci 1980; 27: 475-482.
47. Barron SE, Hoover DB. Localization of acetylcholinesterase and choline acetyltransferase in the rat pituitary gland. Histochem J 1983; 15: 1087-1098.
48. Carmeliet P, Denef C. Immunocytochemical and pharmacological evidence for an intrinsic cholinomimetic system modulating prolactin and growth hormone release in rat pituitary. Endocrinology 1988; 123: 1128-1139.